Global Shortage of Participants Threatens Alzheimer’s Clinical Trials
Audio narration · Coming soon
Alzheimer’s Disease International has warned that a global shortage of participants in clinical trials could slow the development of new dementia therapies. This shortage poses a significant risk to the progress of Alzheimer’s treatment research worldwide.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews